Trial Profile
The Influence of Five Years of Adjuvant Anastrozole or Exemestane on Bone Mineral Density In Postmenopausal Women With Primary Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2023
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Alendronic acid; Anastrozole; Bisphosphonates; Calcium; Calcium carbonate; Calcium citrate; Calcium gluconate; Celecoxib; Colecalciferol; Risedronic acid
- Indications Bone disorders; Early breast cancer
- Focus Adverse reactions
- 23 Mar 2016 New trial record
- 04 Jun 2012 Results from an analysis in women with osteoporosis have been presented at ASCO-2012 according to a Canadian Cancer Society media release.